José Miguel Viegas

Dr. José Miguel Viegas

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2023 in Journal of the American Heart Association
Verified
Journal Article
Open access
PBPedro Garcia Brás
Pedro Garcia Brás
SRSílvia Aguiar Rosa
Sílvia Aguiar Rosa
ICIsabel Cardoso
Isabel Cardoso
LBLuísa Moura Branco
Luísa Moura Branco
AGAna Galrinho
Ana Galrinho
LLLuis R Lopes
Luis R Lopes
Background: Two‐dimensional speckle tracking echocardiography has been shown to correlate with microvascular dysfunction, a hallmark of hypertrophic cardiomyopathy (HCM). We hypothesized that there is an association between myocardial work and left ventricular ischemia, with incremental value to global longitudinal strain, in patients with HCM. Methods and Results: We performed a prospective assessment of patients with HCM, undergoing 2‐dimensional speckle tracking echocardiography and stress perfusion cardiac magnetic resonance. Results were stratified according to obstructive or nonobstructive HCM and the presence of significant replacement fibrosis (late gadolinium enhancement ≥15% of left ventricular mass). Seventy‐five patients with HCM (63% men, age 55±15 years) were evaluated, 28% with obstructive HCM (mean gradient 89±60 mm Hg). Perfusion defects were found in 90.7%, involving 22.5±16.9% of left ventricular mass, and 38.7% had late gadolinium enhancement ≥15%. In a multivariable analysis, a lower global work index ( r =−0.519, β‐estimate −10.822; P =0.001), lower global work efficiency ( r =−0.379, β‐estimate −0.123; P =0.041), and impaired global constructive work ( r =−0.532, β‐estimate −13.788; P −15.5%) had a sensitivity of 64% and a specificity of 57%. The association between myocardial work and perfusion defects was significant independently of late gadolinium enhancement ≥15% and obstructive HCM. Conclusions: Impaired myocardial work was significantly correlated with the extent of ischemia in cardiac magnetic resonance, independently of the degree of left ventricular hypertrophy or fibrosis, with a higher predictive power than global longitudinal strain.

31 October 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
HDHélder Alexandre Correia Dores
Hélder Alexandre Correia Dores
PDPaulo Gomes Dinis
Paulo Gomes Dinis
JVJosé Miguel Viegas
José Miguel Viegas
AFAntónio Freitas
António Freitas
Sports cardiology is an evolving field in cardiology, with several topics remaining controversial. Beyond the several well-known benefits of regular exercise practice, the occurrence of adverse clinical events during sports in apparently healthy individuals, especially sudden cardiac death, and the described long-term adverse cardiac adaptations associated to high volume of exercise, remain challenging. The early identification of athletes with increased risk is critical, but the most appropriate preparticipation screening protocols are also debatable and a more personalized evaluation, considering individual and sports-related characteristics, will potentially optimize this evaluation. As the risk of major clinical events during sports is not zero, independently of previous evaluation, ensuring the capacity for cardiopulmonary resuscitation, especially with availability of automated external defibrillators, in sports arenas, is crucial for its prevention and to improve outcomes. As in other areas of medicine, application of new digital technologies, including artificial intelligence, is promising and could improve in near future several aspects of sports cardiology. This paper aims to review the methodology of athletes’ preparticipation screening, emphasizing current controversies and future challenges, in order to improve early diagnosis of conditions associated with sudden cardiac death.

20 June 2023 in Revista Portuguesa de Cardiologia
Verified
Journal Article
Open access
AGAndré Grazina
André Grazina
AFAntónio Fiarresga
António Fiarresga
RRRuben Ramos
Ruben Ramos
JVJosé Miguel Viegas
José Miguel Viegas
ICIsabel Cardoso
Isabel Cardoso
RFRui Cruz Ferreira
Rui Cruz Ferreira
Transesophageal echocardiography (TEE) has been the standard method for guiding left atrial appendage occlusion (LAAO) procedures. Recently, intracardiac echocardiography (ICE) has emerged as an alternative to TEE due to several advantages, particularly the avoidance of general anesthesia. This analysis aims to assess the safety, feasibility and efficacy of ICE-guided LAAO procedures. We performed a retrospective analysis of ICE-guided LAAO procedures, including a comparison of embolic and bleeding events with the predicted standard scores and a comparison with TEE-guided procedures. A total of 88 patients underwent echocardiography-guided percutaneous LAAO (43 patients with TEE and 45 with ICE), mean age 74.9 years, 68.2% male. In the ICE-guided population, the technical success rate was 93% and the major complication rate was 8.8%. During follow-up, yearly stroke and major bleeding rates were 1.4% and 8.4%, respectively, compared to the 4.0% and 8.7% predicted by the CHA2DS2-VASc and HAS-BLED scores. In the TEE versus ICE analysis (similar baseline characteristics), no statistically significant differences were seen regarding technical success (95.3% vs. 93.3%), procedure-related complications (14.0% vs. 8.9%), device thrombus (2.3% vs. 0%), residual minor peridevice leaks (14.0% vs. 24.4%), one-year all-cause mortality (9.3% vs. 4.4%), stroke (9.3% vs. 2.2%) or major bleeding events (9.3% vs. 11.1%). ICE-guided LAAO was a safe and effective therapeutic strategy in a high embolic and bleeding risk population, compared to the event rates predicted by the CHA2DS2-VASc and HAS-BLED scores. The ICE-guided procedure compared well to TEE-guided procedures regarding procedure feasibility, safety, and efficacy.

7 July 2023 in Revista Portuguesa de Cardiologia
Verified
Journal Article
Open access
AGAndré Grazina
André Grazina
ICIsabel Cardoso
Isabel Cardoso
AFAntónio Fiarresga
António Fiarresga
SRSílvia Aguiar Rosa
Sílvia Aguiar Rosa
PBPedro Garcia Brás
Pedro Garcia Brás
RFRui Cruz Ferreira
Rui Cruz Ferreira
Patients with hypertrophic obstructive cardiomyopathy (HOCM) that remain symptomatic despite optimized medical therapy often undergo alcohol septal ablation (ASA). One of the most frequent complications is complete heart block (CHB), requiring a permanent pacemaker (PPM) in variable rates of up to 20% of patients. The long-term impact of PPM implantation in these patients remains unclear. This study aimed to evaluate the long-term clinical outcomes in patients who implant PPM after ASA. Patients who underwent ASA at a tertiary center were consecutively and prospectively enrolled. Patients with previous PPM or implantable cardio-defibrillator were excluded from this analysis. Patients with and without PPM implantation after ASA were compared based on their baseline characteristics, procedure data and three-year primary endpoint of composite of all-cause mortality and hospitalization and secondary endpoint of composite of all-cause mortality and cardiac cause hospitalization. Between 2009 and 2019, 109 patients underwent ASA, 97 of whom were included in this analysis (68% female, mean age 65.2 years old). 16 patients (16.5%) required PPM implantation for CHB. In these patients, no vascular access, pacemaker pocket or pulmonary parenchyma complications were noted. The baseline characteristics of comorbidities, symptoms, echocardiographic and electrocardiographic findings were identical in the two groups, with higher mean age (70.6±10.0 years vs. 64.1±11.9 years) and lower beta-blocker therapy rate (56% vs. 84%) in the PPM group. Procedure-related data showed higher creatine kinase (CK) peaks in the PPM group (1692 U/L vs. 1243 U/L), with no significant difference in the alcohol dose. At three years after ASA procedure, there were no differences in the primary and secondary endpoints between the two groups. Permanent pacemaker after ASA induced CHB do not affect long term prognosis in hypertrophic obstructive cardiomyopathy patients.

9 September 2023 in Journal of Science and Medicine in Sport
Verified
Journal Article
Closed access
JVJosé Miguel Viegas
José Miguel Viegas
SRSílvia Aguiar Rosa
Sílvia Aguiar Rosa
AFAntónio Freitas
António Freitas

12 February 2024 in REC: Interventional Cardiology
Verified
Journal Article
Open access
JVJosé Miguel Viegas
José Miguel Viegas
RRRuben Ramos
Ruben Ramos
AFAntónio Fiarresga
António Fiarresga
LSLídia Sousa
Lídia Sousa
DYDuarte Cacela Y
Duarte Cacela Y
RFRui Cruz Ferreira
Rui Cruz Ferreira
Revista Española de Cardiología: Interventional Cardiology